Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076822
Company: TEVA PHARMS USA

Products on ANDA 076822

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RABEPRAZOLE SODIUM	RABEPRAZOLE SODIUM	20MG	TABLET, DELAYED RELEASE;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 076822

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/08/2013	ORIG-1	Approval			Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/076822Orig1s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/076822Orig1s000ltr.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/14/2021	SUPPL-13	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
12/04/2018	SUPPL-10	Labeling-Medication Guide, Labeling-Package Insert		Label is not available on this site.
12/04/2018	SUPPL-8	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
12/04/2018	SUPPL-6	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
12/04/2018	SUPPL-5	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
04/03/2015	SUPPL-4	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
04/03/2015	SUPPL-3	Labeling-Medication Guide, Labeling-Package Insert		Label is not available on this site.

Labels for ANDA 076822

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/08/2013	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/076822Orig1s000lbl.pdf